CDMO News
Thermo Fisher and Mainz Biomed Collaborate on Colorectal Cancer Screening Innovation
Thermo Fisher Scientific and Mainz Biomed N.V., a company focused on molecular genetic diagnostics for cancer detection, has announced a new collaboration. Through this agreement, the companies will work together to develop Mainz Biomed’s next-generation mRNA-based screening test for colorectal